Quantifying Gains in Data Quality for Sampling Plans Used in Clinical Trial Monitoring Dennis W. KingMelynda Hazelwood Clinical Trials 01 April 2003 Pages: 135 - 141
Taiwan’s Experience with the Assessment of the Acceptability of the Extrapolation of Foreign Clinical Data for Registration Purposes Yeong-Liang LinHerng-Der ChernMong-Ling Chu Clinical Trials 01 April 2003 Pages: 143 - 145
The Use of Cyclic Redundancy Check (CRC-32) and Adler-32 Checksums for Source Code Verification Allan Glaser Clinical Trials 01 April 2003 Pages: 147 - 154
Hepatotoxicity in the Review of Clinical Safety Data Yeong-Liang LinHerng-Der ChernMong-Ling Chu Drug Regulation 01 April 2003 Pages: 155 - 158
21 CFR Part 11: The Role of Predicate Regulations and Associated Internal Policies Tammala D. Woodrum Drug Regulation 01 April 2003 Pages: 159 - 164
Dimension Change Profile Analysis: A Systematic Approach to Health-Related Quality of Life Instrument Selection in Novel Applications Matthew M. Murawski Statistics 01 April 2003 Pages: 165 - 175
Career Development of Statisticians in the Pharmaceutical Industry Charles L. Liss Statistics 01 April 2003 Pages: 177 - 183
Modeling the Probability-Cost-Profitability Architecture of Portfolio Management in the Pharmaceutical Industry Andreas Zipfel R R&D D Strategy and Management 01 April 2003 Pages: 185 - 205
Project Management as a Discipline within Pharmaceutical Contract Research Organizations Ellis Wilson Jr.James McDonoughJann Nielsen R R&D D Strategy and Management 01 April 2003 Pages: 207 - 213
Good Laboratory Notebook Practices King C. Lee R R&D D Strategy and Management 01 April 2003 Pages: 215 - 219
Exploration of the Relationship between Health-Related Quality of Life and the Price of Pharmaceutical Products Matthew M. MurawskiMarko A. MychaskiwJeffrey Surdej Public Policy and Law 01 April 2003 Pages: 221 - 231
Fee-for-Service Drug Information Centers Miriam A. AnsongMary Lynn MoodyJoan Stachnik Drug Information 01 April 2003 Pages: 233 - 239
A Same-Day Standard for Responding to Drug Information Requests by a Pharmaceutical Company Charles F. CurranMurali N. SundarDaryl R. Wesche Drug Information 01 April 2003 Pages: 241 - 249
5th Middle East Regulatory Conference Paul DeardenKerstin Ahrendt-SölterElaine Whiting Proceedings 01 April 2003 Pages: 251 - 256
